Evidence map›Paper›PMID 28232484›Full record

ArticleThe Journal of biological chemistry2017

Inhibition of virulence-promoting disulfide bond formation enzyme DsbB is blocked by mutating residues in two distinct regions.

Cristina Landeta, Brian M Meehan, Laura McPartland, Linda Ingendahl, Feras Hatahet, Ngoc Q Tran, Dana Boyd, Jon Beckwith

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Anti-Virulence Therapeutic Approaches forAntibiotics (Basel, Switzerland) · 2021
    Review
  8. Article
  9. Article
  10. Disulfide bond formation in prokaryotes.Nature microbiology · 2018
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cristina LandetaFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115.
Brian M MeehanFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115.
Laura McPartlandFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115.
Linda IngendahlFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115.
Feras HatahetFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115.
Ngoc Q TranFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115.
Dana BoydFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115.
Jon BeckwithFrom the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115 Jon_Beckwith@hms.harvard.edu.
Harvard University · US

Funding

Microbial Diversity in Mechanisms of Disulfide Bond Formation and ReductionR01GM041883 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BOYD, DANA · 1989 to 2014
$7.8M
NIGMS NIH HHS R01 GM041883
6 · The paper itself

Abstract

Disulfide bonds contribute to protein stability, activity, and folding in a variety of proteins, including many involved in bacterial virulence such as toxins, adhesins, flagella, and pili, among others. Therefore, inhibitors of disulfide bond formation enzymes could have profound effects on pathogen virulence. In the

Indexed as

MutationAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBacterial ProteinsDisulfidesEscherichia coliEscherichia coli ProteinsGene LibraryKineticsLipopolysaccharidesMembrane ProteinsMutagenesisPolymerase Chain ReactionProtein Disulfide-IsomerasesPyridazinesQuinonesAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBacterial ProteinsDisulfidesdsbA protein, E coliDsbB protein, BacteriaEscherichia coli ProteinsLipopolysaccharidesLptD protein, E coliMembrane ProteinsProtein Disulfide-IsomerasesPyridazinesQuinonesbacteriabacterial geneticsdisulfideEscherichia coli (E. coli)inhibition mechanismlptDpyridazinoneredoxsynthetic lethality

Identifiers

PMID28232484
PMCPMC5399105
OpenAlexW2590837494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.